Get the Stockscreener App
25.75
2.10%
0.53
After Hours:
25.75
Enovis Corp stock is traded at $25.75, with a volume of 768.20K.
It is up +2.10% in the last 24 hours and up +17.21% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$25.22
Open:
$25.6
24h Volume:
768.20K
Relative Volume:
0.68
Market Cap:
$1.48B
Revenue:
$2.28B
Net Income/Loss:
$-1.13B
P/E Ratio:
-1.2966
EPS:
-19.86
Net Cash Flow:
$35.92M
1W Performance:
+14.44%
1M Performance:
+17.21%
6M Performance:
-13.24%
1Y Performance:
-28.35%
1-Day Range:
$24.83
$25.85
1-Week Range:
$22.93
$26.50
52-Week Range:
$19.14
$35.40
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
25.75 | 1.48B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Resumed | William Blair | Outperform |
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
CD&R Engages Former Enovis CEO as Operating Advisor - AOL.com
BMO Capital Initiates Enovis at Outperform With $29 Price Target - marketscreener.com
Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile? - simplywall.st
Enovis (ENOV) Coverage Started with Outperform Rating and $29 Ta - GuruFocus
American Century affiliates report 10.6% holdings in Enovis (ENOV) - Stock Titan
Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus - simplywall.st
Why Enovis (ENOV) Stock Is Trading Up Today - Yahoo Finance
Enovis shares jump after Medicare reverses reimbursement cuts By Investing.com - Investing.com Nigeria
Enovis shares jump after Medicare reverses reimbursement cuts - Investing.com
BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $39 - Moomoo
Enovis Q1 2026 slides: earnings beat forecast, margins expand - Investing.com
Tarkio Fund's Enovis Corp(ENOV) Holding History - GuruFocus
Enovis (ENOV) director Christine Ortiz receives 846-share stock award - Stock Titan
Form 4 Enovis Corp For: 1 July By Investing.com - Investing.com India
Enovis Corp (ENOV) Stock Down 6.0% -- Now Undervalued? GF Score: 60/100 - GuruFocus
How Investors Are Reacting To Enovis (ENOV) Russell 2000 Defensive Index Removal And Rebalancing - simplywall.st
Enovis stock hits 52-week low at 20.45 USD - Investing.com
Enovis stock hits 52-week low at 20.45 USD By Investing.com - Investing.com Australia
Enovis Corporation(NYSE: ENOV) dropped from Russell 2000 Defensive Index - marketscreener.com
Enovis (ENOV) Could Be 46% Undervalued As Net Profit Jumps 84% - simplywall.st
Enterprise value to revenue forward of Enovis Corporation – NYSE:ENOV - TradingView
Enterprise value to revenue forward of Enovis Corporation – LSE:0I1B - TradingView
Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh - TradingView
Enterprise value to EBITDA forward of Enovis Corporation – NYSE:ENOV - TradingView
Price to sales forward of Enovis Corporation – NYSE:ENOV - TradingView
Enovis Corp (ENOV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout | AI
Enovis Corp (ENOV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Enovis Corporation Actuals & Estimates (NYSE:ENOV) - TradingView
C520 Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Enovis Corporation – NYSE:ENOV - TradingView
Enovis Corporation Actuals & Estimates (FWB:C520) - TradingView
ENOV Forecast — Price Target — Prediction for 2027 - TradingView
ENOVEnovis Corp Short Interest - Finviz
Enovis Corp (ENOV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tranche Update on Enovis Corporation's Equity Buyback Plan announced on February 16, 2018. - marketscreener.com
ENOV Technical Analysis & Stock Price Forecast - Intellectia AI
Enovis (ENOV) Slides Over 3% as Shares Approach Key Support at $20.23Imbalance Zone - Město Břeclav
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Raises Target Price to $36 - 富途牛牛
Enovis Corp (ENOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enovis Corp (ENOV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enovis Corp (ENOV) Institutional Confidence - TradingKey
Enovis (ENOV) Q4 2025 earnings summary - Quartr
Enovis Corporation (ENOV) Surges 5.37%: Momentum Building Above Key SupportWyckoff Distribution - dars.gov.et
Enovis Corp (ENOV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Enovis Corp (ENOV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enovis Corp (ENOV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enovis (ENOV) Stock Could Be 49.8% Undervalued After Spinamic Brace Launch - simplywall.st
Insider Buying: Oliver Engert Acquires Additional Shares of Enovis Corp (ENOV) - GuruFocus
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):